Ruta Petraitiene
Overview
Explore the profile of Ruta Petraitiene including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
1449
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kavaliauskas P, Grybaite B, Sapijanskaite-Banevic B, Anusevicius K, Jonuskiene I, Stankeviciene R, et al.
Molecules
. 2024 Jul;
29(13).
PMID: 38999077
Various cancer-associated morbidities remain a growing global health challenge, resulting in a significant burden on healthcare systems worldwide due to high mortality rates and a frequent lack of novel therapeutic...
2.
Petraitis V, Petraitiene R, Kavaliauskas P, Naing E, Garcia A, Zigmantaite V, et al.
Antimicrob Agents Chemother
. 2024 Apr;
68(6):e0020524.
PMID: 38687014
Ventilator-associated bacterial pneumonia (VABP) is among the most intractable of carbapenem-resistant Gram-negative bacterial infections. New antimicrobial agents are critically needed for the treatment of VABP. However, current conventionally used animal...
3.
Petraitiene R, Petraitis V, Zaw M, Hussain K, Ricart Arbona R, Roilides E, et al.
J Fungi (Basel)
. 2024 Apr;
10(4).
PMID: 38667964
Vascular catheter-related infections, primarily caused by and , pose significant challenges due to the formation of biofilms on catheters, leading to refractory disease and considerable morbidity. We studied the efficacy...
4.
Kavaliauskas P, Acevedo W, Garcia A, Naing E, Grybaite B, Sapijanskaite-Banevic B, et al.
PLoS One
. 2024 Mar;
19(3):e0300380.
PMID: 38517855
Antimicrobial resistance (AMR) represents an alarming global challenge to public health. Infections caused by multidrug-resistant Staphylococcus aureus (S. aureus) pose an emerging global threat. Therefore, it is crucial to develop...
5.
Kavaliauskas P, Grybaite B, Sapijanskaite-Banevic B, Vaickelioniene R, Petraitis V, Petraitiene R, et al.
Antibiotics (Basel)
. 2024 Feb;
13(2).
PMID: 38391579
Infections caused by multidrug-resistant bacterial and fungal pathogens represent a significant global health concern, contributing to increased morbidity and mortality rates. Therefore, it is crucial to develop novel compounds targeting...
6.
Bertasiute M, Kavaliauskas P, Vaickelioniene R, Grybaite B, Petraitis V, Petraitiene R, et al.
Int J Mol Sci
. 2023 May;
24(9).
PMID: 37175673
Increasing antimicrobial resistance among Gram-positive pathogens and pathogenic fungi remains one of the major public healthcare threats. Therefore, novel antimicrobial candidates and scaffolds are critically needed to overcome resistance in...
7.
Balandis B, Kavaliauskas P, Grybaite B, Petraitis V, Petraitiene R, Naing E, et al.
Microorganisms
. 2023 Apr;
11(4).
PMID: 37110358
Infections caused by drug-resistant (DR) () complex (MAC) are an important public health concern, particularly when affecting individuals with various immunodeficiencies or chronic pulmonary diseases. Rapidly growing antimicrobial resistance among...
8.
Kavaliauskas P, Grybaite B, Vaickelioniene R, Sapijanskaite-Banevic B, Anusevicius K, Kriauciunaite A, et al.
Antibiotics (Basel)
. 2023 Feb;
12(2).
PMID: 36830130
The growing antimicrobial resistance to last-line antimicrobials among Gram-positive pathogens remains a major healthcare emergency worldwide. Therefore, the search for new small molecules targeting multidrug-resistant pathogens remains of great importance....
9.
Gamaletsou M, Rammaert B, Brause B, Bueno M, Dadwal S, Henry M, et al.
Clin Microbiol Rev
. 2022 Nov;
35(4):e0008619.
PMID: 36448782
Osteoarticular mycoses are chronic debilitating infections that require extended courses of antifungal therapy and may warrant expert surgical intervention. As there has been no comprehensive review of these diseases, the...
10.
Petraitis V, Petraitiene R, Kavaliauskas P, Naing E, Garcia A, Georgiades B, et al.
Antimicrob Agents Chemother
. 2022 Sep;
66(10):e0061822.
PMID: 36154614
Stenotrophomonas maltophilia is an important cause of pneumonia in immunocompromised patients. Cefiderocol is a parenteral siderophore cephalosporin with potent activity against S. maltophilia. We evaluated the efficacy of cefiderocol in...